About DrugBank

The DrugBank database is a comprehensive, freely accessible, online
database containing information on drugs and drug targets. As
both a bioinformatics and a cheminformatics resource, DrugBank combines
detailed drug (i.e. chemical, pharmacological and pharmaceutical) data
with comprehensive drug target (i.e. sequence, structure, and pathway)
information. Because of its broad scope, comprehensive referencing and
unusually detailed data descriptions, DrugBank is more akin to a drug
encyclopedia than a drug database. As a result, links to DrugBank are
maintained for nearly all drugs listed in Wikipedia. DrugBank is widely
used by the drug industry, medicinal chemists, pharmacists, physicians,
students and the general public. Its extensive drug and drug-target
data has enabled the discovery and repurposing of a number of existing
drugs to treat rare and newly identified illnesses.

The latest release of the database (version 5.0) contains 9591 drug
entries including 2037 FDA-approved small molecule drugs, 241 FDA-approved
biotech (protein/peptide) drugs, 96 nutraceuticals and over 6000
experimental drugs. Additionally, 4270 non-redundant protein
(i.e. drug target/enzyme/transporter/carrier) sequences are linked to
these drug entries. Each DrugCard entry contains more than 200
data fields with half of the information being devoted to drug/chemical
data and the other half devoted to drug target or protein data.

DrugBank is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes (including internal use) requires a license. We ask that users who download significant portions of the database cite the DrugBank paper in any resulting publications.